PRESCRIPTION DRUGS REQUIRING PRIOR AUTHORIZATION

Size: px
Start display at page:

Download "PRESCRIPTION DRUGS REQUIRING PRIOR AUTHORIZATION"

Transcription

1 ABSTRAL fentanyl citrate oral tablet ACCU-CHEK TEST STRIPS blood glucose test strips Blood Glucose Test Strips ACTEMRA tocilizumab Monoclonal Antibody ACTHAR corticotropin Hormone ACTIMMUNE interferon gamma 1b Interferon ACTIQ fentanyl citrate OTFC ADCIRCA tadalafil Pulmonary Vasodilator ADEMPAS riociguat Pulmonary Vasodilator ADLYXIN lixisenatide Type 2 Diabetes ADVOCATE TEST STRIPS blood glucose test strips Blood Glucose Test Strips AEROSPAN flunisolide Corticosteroid (Inhaled) AFREZZA insulin Insulin (Inhaled) AIRDUO RESPICLICK fluticasone-salmeterol Beta Adrenergic/Corticosteroid (Inhaled) AKTIPAK benzoyl peroxide-erythromycin Acne Combination ALDARA** imiquimod Immunomodulators Imidazoquinolinamines - Topical ALOGLIPTIN alogliptin Type 2 Diabetes ALOGLIPTIN-METFORMIN alogliptin-metformin Type 2 Diabetes ALTOPREV lovastatin Cholesterol ALVESCO ciclesonide Corticosteroid (Inhaled) AMPYRA dalfampridine Multiple Sclerosis Agent AMRIX cyclobenzaprine Skeletal Muscle Relaxant ANAPROX DS** naproxen sodium Nonsteroidal Anti-inflammatory Agents ANAPROX** naproxen sodium Nonsteroidal Anti-inflammatory Agents ANDRODERM testosterone Topical Testosterone Drug ANDROGEL testosterone Topical Testosterone Drug APIDRA insulin glulisine [rdna origin] Human Insulin Analog APLENZIN bupropion Antidepressant ARANESP darbepoetin alfa Red Blood Cell Progenitor ARCAPTA NEOHALER indacaterol Beta Adrenergic (Inhaled) ARMONAIR RESPICLICK fluticasone propionate Corticosteroid (Inhaled) ARTHROTEC** diclofenac-misoprostol Nonsteroidal Anti-inflammatory Agent Combination ARYMO ER** morphine sulfate extended release 04HQ3249 R10/17 ** Addition to Prior Authorization list effective for 1/1/2018

2 ascomp with codeine** butalbital-aspirin-caffeine-codeine ASMANEX HFA/ TWISTHALER mometasone Corticosteroid (Inhaled) ATRALIN tretinoin Anti-Acne AURYXIA ferric citrate Phosphate Binder AUSTEDO deutetrabenazine Movement Disorder Therapy AUVI-Q epinephrine Non-selective α/β Adrenergic Receptor Agonist AVINZA** morphine sulfate extended release AVITA tretinoin Anti-Acne AXIRON testosterone Topical Testosterone Drug BASAGLAR insulin glargine Human Insulin Analog BELBUCA** buprenorphine hcl belladonna alkaloidsopium** belladonna alkaloids-opium Anticholinergic Combination BENLYSTA belimumab Systemic Lupus Erythematosus Agent BERINERT C1 esterase inhibitor Hereditary Angioedema BETASERON interferon beta-1b Multiple Sclerosis Agent BETHKIS tobramycin Cystic Fibrosis BEVESPI AEROSPHERE glycopyrrolate-formoterol fumarate Beta Adrenergic/Anticholinergic (Inhaled) BIVIGAM immune globulin-intravenous Intravenous Immune Globulin BONIVA SYRINGE ibandronate Osteoporosis/Bones BOTOX onabotulinumtoxina Specialty Drug BRINEURA cerliponase alfa Tripeptidyl Peptidase 1 Deficiency Treatment BRIVIACT Brivaracetam Anticonvulsant BROVANA arformoterol tartrate Beta Adrenergic (Nebulized) BUNAVAIL buprenorphine-naloxone Controlled Dangerous Substance BUPRENORPHINE PATCH** buprenorphine butalbital compoundcodeine** butalbital-aspirin-caffeine-codeine BUTRANS** buprenorphine BYDUREON exenatide extended release Incretin Mimetic Agent BYETTA exenatide Incretin Mimetic Agent CAFERGOT** ergotamine/caffiene Migraine - Ergot Combinations CARAC** fluorouracil Antineoplastic Antimetabolites - Topical

3 CARIMUNE NF immune globulin-intravenous Intravenous Immune Globulin carisoprodol compoundcodeine** carisoprodol-aspirin-codeine Muscle Relaxant Combination carisoprodol-aspirincodeine** carisoprodol-aspirin-codeine Muscle Relaxant Combination CAYSTON aztreonam Cystic Fibrosis CELEBREX** celecoxib Nonsteroidal Anti-inflammatory Agents - COX-2 Inhibitor CHOLBAM cholic acid Bile Acid CIALIS tadalafil Benign Prostatic Hyperplasia CIMZIA certolizumab pegol Anti-Tumor Necrosis Factor Drug CINQAIR reslizumab Monoclonal Antibody CINRYZE C1 esterase inhibitor Hereditary Angioedema codeine sulfate** codeine sulfate COSENTYX secukinumab Interleukin-17 Receptor Antagonist COTEMPLA XR-ODT methylphenidate Stimulant CRESTOR rosuvastatin Cholesterol CUPRIMINE penicillamine Wilson s Disease/Cystinuria/Rheumatoid Arthritis CUVITRU immune globulin-subcutaneous Subcutaneous Immune Globulin D.H.E. 45** dihydroergotamine mesylate Migraine - Ergot Alkaloids and Derivatives DAKLINZA daclatasvir dihydrochloride Hepatitis C DARAPRIM pyrimethamine Antimalarial DAXBIA cephalexin Cephalosporin DAYPRO** oxaprozin Nonsteroidal Anti-inflammatory Agents DEMEROL** meperidine DENAVIR penciclovir Antiviral/Herpes DILAUDID** hydromorphone DOLOPHINE** methadone hcl DUEXIS ibuprofen-famotidine Nonsteroidal Anti-inflammatory Agent Combination DULERA mometasone-formoterol Beta Adrenergic/Corticosteroid (Inhaled) DUPIXENT dupilumab Atopic Dermatitis Monoclonal Antibody DURAGESIC PATCH** fentanyl DURLAZA aspirin extended release Antiplatelet DUZALLO lesinurad-allopurinol Gout Agent

4 DYSPORT abobotulinumtoxina Specialty Drug EC-NAPROSYN** naproxen Nonsteroidal Anti-inflammatory Agents ECOZA econazole Antifungal EFUDEX** fluorouracil Antineoplastic Antimetabolites - Topical EGRIFTA tesamorelin HIV Associated Lipodystrophy ELIDEL pimecrolimus Immunomodulator EMBEDA ** morphine-naltrexone EMBRACE PRO TEST STRIPS blood glucose test strips Blood Glucose Test Strips EMFLAZA deflazacort Corticosteroid EMLA** lidocaine-prilocaine Local Anesthetics - Topical ENBREL etanercept Anti-Tumor Necrosis Factor Drug ENDARI glutamine Amino Acids Sickle Cell endocet** oxycodone-acetaminophen ENDODAN** oxycodone-aspirin ENTYVIO vedolizumab Monoclonal Antibody EPCLUSA sofosbuvir-velpatasvir Hepatitis C EPOGEN epoetin alfa Red Blood Cell Progenitor ERGOMAR** ergotamine Migraine - Ergot Alkaloids and Derivatives ERTACZO sertaconazole Antifungal ESBRIET pirfenidone Pulmonary Fibrosis EUCRISA crisaborole Phosphodiesterase 4 Inhibitor EUFLEXXA sodium hyaluronate Hyaluronic Acid Derivatives for Joint Injection EVENCARE MINI GLUCOSE TEST STRIPS blood glucose test strips Blood Glucose Test Strips EVZIO naloxone hcl injection Opiate Reversal Agent EXALGO** hydromorphone hcl extended release EXELDERM sulconazole Antifungal EXONDYS 51 eteplirsen Duchenne Muscular Dystrophy EXTINA ketoconazole Antifungal FELDENE** piroxicam Nonsteroidal Anti-inflammatory Agents FENOPROFEN CALCIUM** fenoprofen calcium Nonsteroidal Anti-inflammatory Agents FENORTHO** fenoprofen calcium Nonsteroidal Anti-inflammatory Agents FENTANYL PATCH** fentanyl

5 FENTORA fentanyl buccal tablet FEXMID cyclobenzaprine Skeletal Muscle Relaxant FIORICET-CODEINE** bultabital-acetaminophen-caffeinecodeine FIORINAL-CODEINE** butalbital-aspirin-caffiene-codeine FIRAZYR icatibant Hereditary Angioedema FLEBOGAMMA immune globulin-intravenous Intravenous Immune Globulin FLECTOR** diclofenac epolamine Anti-inflammatory Agents - Topical FLEXERIL cyclobenzaprine Skeletal Muscle Relaxant FLOLAN epoprostenol sodium Pulmonary Vasodilator FLOLIPID simvastatin-suspension Cholesterol FLUOROPLEX** fluorouracil Antineoplastic Antimetabolites - Topical FLUOROURACIL 0.5% cream** fluorouracil Antineoplastic Antimetabolites - Topical FORADIL AEROLIZER formoterol Beta Adrenergic (Inhaled) FORFIVO XL bupropion Antidepressant FORTAMET metformin Type 2 Diabetes FORTEO teriparatide Osteoporosis/Bones FORTESTA testosterone Topical Testosterone Drug FOSRENOL lanthanum carbonate Phosphate Binder FREESTYLE TEST STRIPS blood glucose test strips Blood Glucose Test Strips GAMIMUNE N immune globulin-intravenous Intravenous Immune Globulin GAMMAGARD LIQUID immune globulin-intravenous Intravenous Immune Globulin GAMMAGARD S/D immune globulin-intravenous Intravenous Immune Globulin GAMMAKED immune globulin-intravenous Intravenous Immune Globulin GAMMAPLEX immune globulin-intravenous Intravenous Immune Globulin GAMMAR-P IV immune globulin-intravenous Intravenous Immune Globulin GAMUNEX immune globulin-intravenous Intravenous Immune Globulin GAMUNEX-C immune globulinintravenous/subcutaneous Intravenous/Subcutaneous Immune Globulin GATTEX teduglutide [rdna origin] Short Bowel Syndrome GEL-ONE sodium hyaluronate Hyaluronic Acid Derivative for Joint Injection GEL-SYN sodium hyaluronate Hyaluronic Acid Derivative for Joint Injection GENOTROPIN somatropin Growth Hormone GENSTRIP TEST STRIPS blood glucose test strips Blood Glucose Test Strips

6 GENVISC 850 sodium hyaluronate Hyaluronic Acid Derivatives for Joint Injection GLUCOPHAGE XR metformin Type 2 Diabetes GLUCOSE TEST STRIP blood glucose test strips Blood Glucose Test Strips GLUMETZA metformin Type 2 Diabetes GOCOVRI amantadine Antiparkinson Dopaminergics GRALISE gabapentin Postherpetic Neuralgia Agent GRASTEK timothy grass pollen allergen extract Allergy Immunotherapy HAEGARDA C1 esterase inhibitor Hereditary Angioedema HARVONI ledipasvir-sofosbuvir Hepatitis C HETLIOZ tasimelteon Non-24-Hour Sleep-Wake Disorder HIZENTRA immune globulin-subcutaneous Subcutaneous Immune Globulin HORIZANT gabapentin enacarbil Restless Legs Syndrome/Postherpetic Neuralgia HUMALOG insulin lispro [rdna origin] Human Insulin Analog HUMATROPE somatropin Growth Hormone HUMIRA adalimumab Monoclonal Antibody HUMULIN insulin human [rdna origin] Human Insulin HYALGAN sodium hyaluronate Hyaluronic Acid Derivative for Joint Injection HYCET** hydrocodone-acetaminophen HYMOVIS sodium hyaluronate Hyaluronic Acid Derivative for Joint Injection HYQVIA immune globulin-subcutaneous Subcutaneous Immune Globulin HYSINGLA ER** hydrocodone bitartrate extended release IBUDONE** hydrocodone-ibuprofen ILUVIEN fluocinolone acetonide Ophthalmic Steroids IMPAVIDO miltefosine Antileishmanial INCRELEX mecasermin Growth Hormone INDOCIN** indomethacin Nonsteroidal Anti-inflammatory Agents INFLECTRA infliximab-dyyb Monoclonal Antibody INGREZZA valbenazine Movement Disorder Therapy IVEEGAM EN immune globulin-intravenous Intravenous Immune Globulin IVIG OR IGIV immune globulin-intravenous Intravenous Immune Globulin JUBLIA efinaconazole Antifungal JUXTAPID lomitapide Homozygous Familial Hypercholesterolemia

7 KADIAN** morphine sulfate extended release KALBITOR ecallantide Hereditary Angioedema KALYDECO ivacaftor Cystic Fibrosis KANUMA sebelipase alfa Enzyme KAZANO alogliptin-metformin Type 2 Diabetes KERYDIN tavaborole Antifungal ketoprofen er** ketoprofen extended release Nonsteroidal Anti-inflammatory Agents KEVEYIS dichlorphenamide Carbonic Anhydrase Inhibitor KEVZARA sarilumab Monoclonal Antibody KINERET** anakinra Interleukin-1 Receptor Antagonist KOMBIGLYZE XR saxagliptin-metformin Type 2 Diabetes KORLYM mifepristone Endocrine/Cushing s Disease KRYSTEXXA pegloticase Gout KUVAN sapropterin Phenylketonuria KYMRIAH tisagenlecleucel Oncology KYNAMRO mipomersen Homozygous Familial Hypercholesterolemia LAZANDA NASAL SPRAY fentanyl citrate LEMTRADA alemtuzumab Multiple Sclerosis LETAIRIS ambrisentan Pulmonary Vasodilator LEVALBUTEROL HFA levalbuterol tartrate Short Acting Beta Adrenergic (Inhaled) levorphanol** levorphanol tartrate LIBERTY TEST STRIP blood glucose test strips Blood Glucose Test Strips lidocaine ointment 5%** lidocaine Local Anesthetics - Topical LIDODERM lidocaine Topical Anesthetic LIVALO pitavastatin calcium Cholesterol LOCORT dexamethasone Glucocorticosteroid LODINE** etodolac Nonsteroidal Anti-inflammatory Agents lorcet (hd/plus)** hydrocodone-acetaminophen LORTAB** hydrocodone-acetaminophen LOVAZA omega-3-acid ethyl esters Omega-3 Fatty Acid LUMIGAN bimatoprost Anti-Glaucoma LUZU luliconazole Antifungal MAKENA hydroxyprogesterone Hormone

8 MAVYRET glecaprevir-pibrentasvir Hepatitis C MENTAX butenafine Antifungal methadose** methadone hcl migergot** ergotamine/caffiene Migraine - Ergot Combinations MIGRANAL** dihydroergotamine mesy Migraine - Ergot Alkaloids and Derivatives MIRCERA pegylated epoetin beta Red Blood Cell Progenitor MOBIC** meloxicam Nonsteroidal Anti-inflammatory Agents MONOVISC sodium hyaluronate Hyaluronic Acid Derivatives for Joint Injection MORPHABOND ER** morphine sulfate extended release morphine sulfate** morphine sulfate MS CONTIN** morphine sulfate controlled and extended release MYALEPT metreleptin Leptin Analog MYOBLOC rimabotulinumtoxinb Specialty Drug NAFTIN naftifine Antifungal NALFON** fenoprofen calcium Nonsteroidal Anti-inflammatory Agents NAPRELAN CR** naproxen sodium controlled and extended release Nonsteroidal Anti-inflammatory Agents NAPRELAN** naproxen sodium Nonsteroidal Anti-inflammatory Agents NAPROSYN** naproxen Nonsteroidal Anti-inflammatory Agents NATESTO testosterone Topical Testosterone Drug NESINA alogliptin Type 2 Diabetes NEURONTIN gabapentin Postherpetic Neuralgia/Anticonvulsant NITYR nitisinone Heredeitary Tyrosinemia Type 1 NORCO** hydrocodone-acetaminophen NORDITROPIN somatropin Growth Hormone NORTHERA droxidopa Neurogenic Orthostatic Hypotension NUCALA mepolizumab Monoclonal Antibody NUCYNTA ER** tapentadol hcl extended release NUCYNTA** tapentadol hcl NUTROPIN somatropin Growth Hormone NUTROPIN AQ somatropin Growth Hormone NUVIGIL armodafinil CNS Stimulant OCALIVA obeticholic acid Bile Acid Analog

9 OCREVUS ocrelizumab Monoclonal Antibody OCTAGAM immune globulin-intravenous Intravenous Immune Globulin OFEV nintedanib Pulmonary Fibrosis OLYSIO simeprevir Hepatitis C OMNITROPE somatropin Growth Hormone ONE TOUCH TEST STRIPS blood glucose test strips Blood Glucose Test Strips ONE TOUCH ULTRA TEST STRIPS blood glucose test strips Blood Glucose Test Strips ONGLYZA saxagliptin Type 2 Diabetes ONMEL itraconazole Antifungal ONSOLIS fentanyl soluble film ONZETRA XSAIL sumatriptan succinate Migraine Therapy Selective Serotonin Agonists OPANA ER** oxymorphone hcl extended release OPANA** oxymorphone hcl OPSUMIT macitentan Pulmonary Vasodilator sweet vernal-orchard-perennial rye- ORALAIR timothy-kentucky blue grass mixed Allergy Immunotherapy pollens allergen extract ORAVIG miconazole Antifungal ORENCIA/CLICKJECT abatacept Selective Co-Stimulation Modulator for RA ORENITRAM/ER treprostinil Pulmonary Vasodilator ORFADIN** nitisinone Heredeitary Tyrosinemia Type 1 ORKAMBI lumacaftor-ivacaftor Cystic Fibrosis ORTHOVISC high molecular weight hyaluronan Hyaluronic Acid Derivative for Joint Injection OTEZLA apremilast Phosphodiesterase Inhibitor OTREXUP methotrexate Rheumatoid Arthritis/Polyarticular Juvenile Idiopathic Arthritis/Psoriasis OXAYDO** oxycodone hcl OXISTAT oxiconazole Antifungal OXYCODONE ER** oxycodone hcl extended release oxycodone-ibuprofen** oxycodone-ibuprofen OXYCONTIN** oxycodone hcl extended release OZURDEX dexamethasone Ophthalmic Steroids PEGASYS peginterferon alfa-2a Interferon PEG-INTRON peginterferon alfa-2b Interferon

10 PENNSAID** diclofenac sodium Anti-inflammatory Agents - Topical PERCOCET** oxycodone-acetaminophen PERCODAN** oxycodone-aspirin PERFOROMIST formoterol fumarate Beta Adrenergic (Nebulized) PHOSLO calcium acetate Phosphate Binder PHOSLYRA calcium acetate Phosphate Binder POLYGAM S/D immune globulin-intravenous Intravenous Immune Globulin PONSTEL** mefenamic acid Nonsteroidal Anti-inflammatory Agents PRADAXA dabigatran etexilate Anticoagulant PRALUENT alirocumab Cholesterol PRECISION SOF-TACT TEST STRIPS blood glucose test strips Blood Glucose Test Strips PRECISION XTRA TEST STRIPS blood glucose test strips Blood Glucose Test Strips PRILOSEC DR** Omeprazole Proton Pump Inhibitor PRIMLEV** oxycodone-acetaminophen PRIVIGEN immune globulin-intravenous Intravenous Immune Globulin PROCRIT epoetin alfa Red Blood Cell Progenitor PROCYSBI cysteamine bitartrate Nephropathic Cystinosis Agent PRODIGY TEST STRIPS blood glucose test strips Blood Glucose Test Strips PROLIA denosumab Osteoporosis/Bones PROTOPIC tacrolimus Immunomodulator PROVENGE sipuleucel-t Oncology PROVENTIL HFA albuterol Short Acting Beta Adrenergic (Inhaled) PROVIGIL modafinil CNS Stimulant prudoxin** doxepin Antipruritics - Topical PULMICORT FLEXHALER budesonide Corticosteroid (Inhaled) QUDEXY XR topiramate extended release Anticonvulsant QUTENZA capsaicin Topical Anesthetic RADICAVA edaravone Amyotrophic Lateral Sclerosis (ALS) Agent RAGWITEK short ragweed pollen allergen extract Allergy Immunotherapy RAYALDEE calcifediol Vitamin D3 analog RAYOS prednisone Corticosteroid RECLAST zoledronic acid Osteoporosis/Bones

11 RELION TEST STRIPS blood glucose test strips Blood Glucose Test Strips REMICADE infliximab Monoclonal Antibody REMODULIN treprostinil sodium Pulmonary Vasodilator RENAGEL sevelamer Phosphate Binder RENFLEXIS infliximab-abda Monoclonal Antibody RENVELA sevelamer carbonate Phosphate Binder REPATHA evolocumab Cholesterol reprexain** hydrocodone-ibuprofen RESCULA unoprostone isopropyl Anti-Glaucoma RETIN-A tretinoin Anti-Acne RETIN-A MICRO tretinoin Anti-Acne RETISERT fluocinolone acetonide Ophthalmic Steroids REVATIO sildenafil citrate Pulmonary Vasodilator RHOFADE oxymetazoline Rosacea Agent RITUXAN rituximab Monoclonal Antibody RITUXAN HYCELA rituximab-hyaluronidase Monoclonal Antibody roxicet** oxycodone-acetaminophen ROXICODONE** oxycodone hcl RUCONEST C1 esterase inhibitor (recombinant) Hereditary Angioedema RYVENT carbinoxamine Antihistamine SABRIL vigabatrin Anticonvulsant SAIZEN/SAIZENPREP somatropin Growth Hormone SAVAYSA edoxaban Anticoagulant SEEBRI NEOHALER glycopyrrolate Anticholinergic SEROSTIM somatropin Growth Hormone SIGNIFOR pasireotide Somatostatin/Cushing s Disease SIGNIFOR LAR pasireotide Somatostatin/Acromegaly SILIQ brodalumab Monoclonal Antibody SIMPONI golimumab Anti-Tumor Necrosis Factor Drug SITAVIG acyclovir Antiviral/Herpes SOLARAZE** diclofenac Antineoplastic or Premalignant Lesions - Topical NSAID SOLIQUA insulin glargine-lixisenatide Human Insulin Analog SOVALDI sofosbuvir Hepatitis C

12 SPINRAZA nusinersen Exon Inclusion Antisense Oglionucleotide SPRITAM levetiracetam Anticonvulsant SPRIX** ketorolac tromethamine Nonsteroidal Anti-inflammatory Agents STELARA ustekinumab Anti-Tumor Necrosis Factor Drug STRENSIQ asfotase alfa Hypophosphatasia STRIANT testosterone Topical Testosterone Drug SUBOXONE SL FILM buprenorphine-naloxone Controlled Dangerous Substance SUBOXONE SL TABLETS buprenorphine-naloxone Controlled Dangerous Substance SUBSYS fentanyl sublingual spray Controlled Dangerous Substance SUBUTEX buprenorphine Controlled Dangerous Substance SUPARTZ sodium hyaluronate Hyaluronic Acid Derivatives for Joint Injection SYMLIN pramlintide Amylin Analogue SYNAGIS palivizumab Monoclonal Antibody SYNALGOS-DC** aspirin-caffeine-dihydrocodeine SYNDROS dronabinol Antiemetics SYNVISC hylan GF 20 Hyaluronic Acid Derivatives for Joint Injection SYNVISC-ONE hylan GF 20 Hyaluronic Acid Derivatives for Joint Injection SYPRINE trientine Wilson s Disease TALTZ ixekizumab Monoclonal Antibody TANZEUM albiglutide Incretin Mimetic Agent TECHNIVIE ombitasvir-paritaprevir-ritonavir Hepatitis C TESTIM testosterone Topical Testosterone Drug TESTOSTERONE testosterone Topical Testosterone Drug TEV-TROPIN somatropin Growth Hormone TIVORBEX** indomethacin Nonsteroidal Anti-inflammatory Agents TOBI/TOBI PODHALER tobramycin Cystic Fibrosis TOLAK** fluorouracil Antineoplastic Antimetabolites - Topical tolmetin** tolmetin sodium Nonsteroidal Anti-inflammatory Agents TOPIRAMATE ER topiramate extended release Anticonvulsant TRACLEER bosentan Pulmonary Vasodilator TRAVATAN Z travoprost Anti-Glaucoma TREMFYA guselkumab Monoclonal Antibody TRETIN-X tretinoin Anti-Acne

13 TREZIX** acetaminophen-caffeinedihydrocodeine TRIMPEX trimethoprim Anti-Infective Agents TROKENDI XR topiramate extended release Anticonvulsant TRULANCE plecanatide Chronic Idiopathic Constipation Agents TRULICITY dulaglutide Incretin Mimetic Agent TUDORZA PRESSAIR aclidinium Anticholinergic (Inhaled) TYLENOL WITH CODEINE** acetaminophen-codeine TYMLOS abaloparatide Osteoporosis/Bones TYSABRI natalizumab Monoclonal Antibody TYVASO treprostinil Pulmonary Vasodilator UNISTRIP1 blood glucose test strips Blood Glucose Test Strips UPTRAVI selexipag Pulmonary Vasodilator UTIBRON NEOHALER Indacaterol-glycopyrrolate Beta Adrenergic/Anticholinergic (Inhaled) VASCEPA icosapent ethyl Omega-3 Fatty Acid VECAMYL mecamylamine hydrochloride Hypertension VELETRI epoprostenol sodium Pulmonary Vasodilator VELPHORO sucroferric oxyhydroxide Phosphate Binder VELTIN tretinoin-clindamycin Anti-Acne VENTAVIS iloprost Pulmonary Vasodilator verdrocet** hydrocodone-acetaminophen vicodin (es/hp)** hydrocodone-acetaminophen VICOPROFEN** hydrocodone-ibuprofen VICTOZA liraglutide Incretin Mimetic Agent VIEKIRA PAK/XR ombitasvir-paritaprevir-ritonavirdasabuvir Hepatitis C VIMOVO naproxen-esomeprazole Nonsteroidal Anti-inflammatory Agent magnesium Combination VIVLODEX** meloxicam Nonsteroidal Anti-inflammatory Agents VOGELXO testosterone Topical Testosterone Drug VOLTAREN** diclofenac sodium Anti-inflammatory Agents - Topical VOLTAREN-XR** diclofenac sodium Nonsteroidal Anti-inflammatory Agents VOSEVI sofosbuvir-velpatasvir-voxilaprevir Hepatitis C

14 WAVESENSE TEST STRIPS blood glucose test strips Blood Glucose Test Strips WELLBUTRIN SR/XL bupropion Antidepressant XADAGO safinamide mesylate Antiparkinson Monoamine Oxidase Inhibitor XALATAN latanoprost Anti-Glaucoma XARTEMIS XR** oxycodone-acetaminophen XATMEP methotrexate Acute Lymphoblastic Leukemia/Polyarticular Jevnile Idiopathic Arthritis XELJANZ/XR tofacitinib Janus Kinase Inhibitor XENAZINE tetrabenazine Huntington s Chorea XEOMIN incobotulinumtoxina Specialty Drug XERMELO telotristat etiprate Carcinoid Syndrome Diarrhea XGEVA denosumab Oncology/Bones XIAFLEX collagenase clostridium Cord Injection XODOL** hydrocodone-acetaminophen XOLAIR omalizumab Monoclonal Antibody XOLEGEL ketoconazole Antifungal XOLOX** oxycocodone-acetaminophen XOPENEX HFA levalbuterol Short Acting Beta Adrenergic (Inhaled) XTAMPZA ER** oxycodone extended release XULTOPHY insulin degludec-liraglutide Insulin/Incretin Mimetic Agent XURIDEN uridine triacetate granule Hereditary Orotic Aciduria xylon** hydrocodone-ibuprofen XYREM sodium oxybate Narcolepsy zamicet** hydrocodone-acetaminophen ZEMBRACE SYMTOUCH sumatriptan injection Migraine Therapy Selective Serotonin Agonists ZEPATIER elbasvir-grazoprevir Hepatitis C ZIANA tretinoin-clindamycin Anti-Acne ZINBRYTA daclizumab Monoclonal Antibody ZINPLAVA bezlotoxumab Bacterial Monoclonal Antibodies ZIOPTAN tafluprost Anti-Glaucoma ZIPSOR** diclofenac potassium Nonsteroidal Anti-inflammatory Agents ZODEX dexamethasone Glucocorticosteroid ZOHYDRO ER** hydrocodone bitartrate extended release

15 ZOMACTON somatropin Growth Hormone ZOMETA zoledronic acid Oncology/Bones ZONACORT dexamethasone Glucocorticosteroid ZONALON** doxepin Antipruritics - Topical ZORBTIVE somatropin Growth Hormone ZORVOLEX** diclofenac Nonsteroidal Anti-inflammatory Agents ZOVIRAX CREAM/OINTMENT acyclovir Antiviral/Herpes ZUBSOLV buprenorphine-naloxone Controlled Dangerous Substance ZURAMPIC lesinurad Uric Acid Transporter 1 inhibitor ZYFLO zileuton Asthma Therapy ZYFLO CR zileuton controlled release Asthma Therapy

PRESCRIPTION DRUGS REQUIRING PRIOR AUTHORIZATION

PRESCRIPTION DRUGS REQUIRING PRIOR AUTHORIZATION Abstral fentanyl citrate oral tablet Controlled Dangerous substance Actemra tocilizumab Monoclonal antibody Acthar corticotropin Hormone Actimmune interferon gamma 1b Interferon Actiq fentanyl citrate

More information

PRESCRIPTION DRUGS REQUIRING PRIOR AUTHORIZATION

PRESCRIPTION DRUGS REQUIRING PRIOR AUTHORIZATION Abstral fentanyl citrate oral tablet Controlled Dangerous substance Actemra tocilizumab Monoclonal antibody Acthar corticotropin Hormone Actimmune interferon gamma 1b Interferon Actiq fentanyl citrate

More information

METABOLIC, IMMUNE DISORDERS OR INHERITED RARE DISEASE ALPHA-1 PROTEINASE INHIBITORS ARANESP BLOOD CELL DEFICIENCY ARANESP ARCALYST

METABOLIC, IMMUNE DISORDERS OR INHERITED RARE DISEASE ALPHA-1 PROTEINASE INHIBITORS ARANESP BLOOD CELL DEFICIENCY ARANESP ARCALYST PRIOR AUTHORIZATION LIST (SUBJECT TO CHANGE) MEDICATION THERAPEUTIC CATEGORY MODULE ACTEMRA INFLAMMATORY CONDITIONS ACTEMRA ADCIRCA PULMONARY HYPERTENSION PDE-5 INHIBITORS FOR PAH ADDYI SEXUAL DISORDERS

More information

PRESCRIPTION DRUGS REQUIRING PRIOR AUTHORIZATION

PRESCRIPTION DRUGS REQUIRING PRIOR AUTHORIZATION Abstral fentanyl citrate oral tablet Controlled Dangerous Substance Accu-Chek Test Strips blood glucose test strips Blood Glucose Test Strips Actemra tocilizumab Monoclonal Antibody Acthar corticotropin

More information

Pulmonary Hypertension Weight Loss Skin Conditions. Skin Conditions Multiple Sclerosis Endocrine Disorder. Endocrine Disorder.

Pulmonary Hypertension Weight Loss Skin Conditions. Skin Conditions Multiple Sclerosis Endocrine Disorder. Endocrine Disorder. Prior Authorization PricewaterhouseCoopers The following medications may require prior authorization prior to dispensing at a participating retail pharmacy or through the Express Scripts Pharmacy home

More information

List of Designated High-Cost Drugs

List of Designated High-Cost Drugs List of Designated High-Cost Drugs UPDATED APRIL 25, 2018 For details on the High-Cost Drug policy, see Section 5.8 of the PharmaCare Policy Manual. Recent updates appear in red. Deletions are listed at

More information

Exclusion Reasons Presumption of Long- Term Non-Acute Administration C9399 Unclassified Drugs or

Exclusion Reasons Presumption of Long- Term Non-Acute Administration C9399 Unclassified Drugs or Noridian Healthcare Solutions, LLC Jurisdiction F Part B Self-Administered Drug (SAD) Exclusion List (A53033); Effective 8/7/2017 The following medications are considered self-administered and are not

More information

DRUGS REQUIRING PRIOR AUTHORIZATION

DRUGS REQUIRING PRIOR AUTHORIZATION DRUGS REQUIRING PRIOR AUTHORIZATION Medication Abstral Actemra Acthar Gel Actiq* Adcirca Adderall Adderall XR Addyi Adempas Adipex* Adzenys XR-ODT Afinitor Afinitor Alecensa Alecensa Ampyra Androderm AndroGel

More information

SELF-ADMINISTERED MEDICATIONS LIST

SELF-ADMINISTERED MEDICATIONS LIST SELF-ADMINISTERED MEDICATIONS LIST Table of Contents Page Last Updated: January 23, 2019 INSTRUCTIONS FOR USE... 1 APPLICABLE CODES... 1 Related Commercial Policy LIST HISTORY/REVISION INFORMATION... 5

More information

These programs and quantity limitations may not apply. Check your certificate or other plan information for benefit details.

These programs and quantity limitations may not apply. Check your certificate or other plan information for benefit details. FlexRx Standard Utilization Management (PA, QL,) Updates January 1, 2018 How to use this drug list This drug list includes updates to Utilization Management (UM) programs. UM may include a prior authorization

More information

Capital BlueCross Open/Closed Formulary Update (1 st Quarter 2017)

Capital BlueCross Open/Closed Formulary Update (1 st Quarter 2017) Capital BlueCross Open/Closed Formulary Update (1 st Quarter 2017) The Capital BlueCross formulary is a reference list of prescription drugs that contains a wide range of generic and brand drugs that have

More information

** Fee-For-Service Pharmacy Provider Notice #229 May 2018 PDL Changes **

** Fee-For-Service Pharmacy Provider Notice #229 May 2018 PDL Changes ** ** Fee-For-Service Pharmacy Provider Notice #229 May 2018 PDL Changes ** August 03, 2018 Please be advised that the Department for Medicaid Services (DMS) is making changes to the Kentucky Medicaid Fee-For-Service

More information

Prior Authorization Program Information (Effective April 1st, 2018)

Prior Authorization Program Information (Effective April 1st, 2018) Prior Authorization Program Information (Effective April 1st, 2018) Prior Authorization Certain drugs require prior authorization to help promote safe, quality and affordable pharmacy care. Your doctor

More information

Drug Formulary Update, January 2018 Commercial and State Programs

Drug Formulary Update, January 2018 Commercial and State Programs Drug Formulary Update, January 2018 Commercial and State Programs Updates to the HealthPartners Commercial and State Program Drug Formularies are listed below. Updates apply to all Commercial groups (PreferredRx,

More information

Cigna Drug and Biologic Coverage Policy

Cigna Drug and Biologic Coverage Policy Cigna Drug and Biologic Coverage Policy Subject Controlled Substance Analgesic and Narcotic Antagonist Quantity Limitations Table of Contents Coverage Policy... 1 General Background... 6 Coding/Billing

More information

PRESCRIPTION DRUG LIST CHANGES

PRESCRIPTION DRUG LIST CHANGES PRESCRIPTION DRUG LIST CHANGES Cigna Pharmacy Management The medications listed below are changing coverage (or cost levels) on Cigna s Prescription Drug List. Changes are listed by drug list and by the

More information

Drug Name. J0129 Injection, abatacept (Orencia ), 10 mg Effective 01/01/2014. J0178 Injection, aflibercept (Eylea ), 1 mg Effective 04/01/2015

Drug Name. J0129 Injection, abatacept (Orencia ), 10 mg Effective 01/01/2014. J0178 Injection, aflibercept (Eylea ), 1 mg Effective 04/01/2015 J0129 Injection, abatacept (Orencia ), 10 J0178 Injection, aflibercept (Eylea ), 1 J0256 J0257 J0585 J0586 J0587 J0588 J0597 J0641 J0717 J0800 Injection, alpha 1-proteinase inhibitor, human (Aralast NP,

More information

BCBS AZ ADV PLUS * CLASSIC * PREMIER For use with members associated with the BHN Network Prior Authorization List 2015

BCBS AZ ADV PLUS * CLASSIC * PREMIER For use with members associated with the BHN Network Prior Authorization List 2015 Prior Authorization List 2015 Participating providers are responsible to furnish or arrange health care services with other participating healthcare facilities or providers. Prior authorization requests

More information

Added, Removed or Changed. Date of Change. No Change

Added, Removed or Changed. Date of Change. No Change One mission: you s September 7, 2017 Blue Cross of Idaho reviews its formularies (covered drug lists) periodically to allow members access to new drugs and to provide safe, cost effective options for your

More information

Xyrem (Sodium Oxybate)

Xyrem (Sodium Oxybate) Texas Prior Authorization Program Clinical Criteria Drug/Drug Class Clinical Criteria Information Included in this Document Drugs requiring prior authorization: the list of drugs requiring prior authorization

More information

UPMC for You Pharmacy and Therapeutics Committee Meeting July 22, 2014 meeting

UPMC for You Pharmacy and Therapeutics Committee Meeting July 22, 2014 meeting UPMC for You Pharmacy and Therapeutics Committee Meeting July 22, 2014 meeting 1. Call to order: The meeting was called to order at 7:05 a.m. 2. Review of the minutes: The minutes of the April meeting

More information

OptumRx Focused Utilization Management Program

OptumRx Focused Utilization Management Program Utilization management updates - January 1, 2019 OptumRx Focused Utilization Management Program OptumRx focused step therapy with quantity limits programs If you have a prescription for any of the Step

More information

TRICARE Uniform Formulary. Pre-Authorization Requirements

TRICARE Uniform Formulary. Pre-Authorization Requirements TRICARE Uniform Formulary Pre-Authorization Requirements The Department of Defense (DoD) requires pre-authorization on select medications. These medications are on the DoD s pre-authorization list because

More information

RAHF PFM ALPHANINE SD COAGULATION FACTOR IX J7193 COAGULATION FACTOR IX (RFIXFC)

RAHF PFM ALPHANINE SD COAGULATION FACTOR IX J7193 COAGULATION FACTOR IX (RFIXFC) INFECTIOUS DISEASE ACTIMMUNE INTERFERON GAMMA 1B J9216 ADVATE RAHF PFM ONCOLOGY ORAL AFINITOR EVEROLIMUS J7527 INFECTIOUS DISEASE ALFERON N INTERFERON ALFA N3 J9215 ALPHANATE VWF J7186 ALPHANINE SD J7193

More information

ALLERGIC RHINITIS-NASAL

ALLERGIC RHINITIS-NASAL ALLERGIC RHINITIS-NASAL FLUNISOLIDE Patient needs to have paid claims for any one of the following Step 1 drugs: NasaCort OTC, fluticasone Rx, fluticasone OTC, Budesonide OTC. Prior to filling the Step

More information

Future Formulary Changes

Future Formulary Changes Future Formulary Changes Upd 09/11/2018 Applies to: Employer group plan 2018 open formularies KEY: =prior authorization; ST=step therapy; QL=quantity limit Generic name Brand name Change Effective Hydroxyprogesterone

More information

UPMC for You Pharmacy and Therapeutics Committee Meeting April 7, 2014 meeting

UPMC for You Pharmacy and Therapeutics Committee Meeting April 7, 2014 meeting UPMC for You Pharmacy and Therapeutics Committee Meeting April 7, 2014 meeting 1. Call to order: The meeting was called to order at 7:05 a.m. 2. Review of the minutes: The minutes of the January meeting

More information

CHANGES TO YOUR DRUG LIST

CHANGES TO YOUR DRUG LIST CHANGES TO YOUR DRUG LIST More generics and lower-cost brands to help you stay healthy and save money At Cigna, it s our goal to offer you access to coverage for safe, effective and affordable medications.

More information

APPROVED PA CRITERIA. Initial Approval: January 10, 2018 Revised Dates: April 11, 2018 CRITERIA FOR PRIOR AUTHORIZATION

APPROVED PA CRITERIA. Initial Approval: January 10, 2018 Revised Dates: April 11, 2018 CRITERIA FOR PRIOR AUTHORIZATION Initial Approval: January 10, 2018 Revised Dates: April 11, 2018 CRITERIA FOR PRIOR AUTHORIZATION PROVIDER GROUP Pharmacy Opioid Products Indicated for Pain Management MANUAL GUIDELINES All dosage forms

More information

Opiate/Benzodiazepine/Muscle Relaxant Combinations

Opiate/Benzodiazepine/Muscle Relaxant Combinations Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Opiate/Benzodiazepine/Muscle Relaxant Combinations Clinical Edit Information Included in this Document Drugs requiring prior authorization:

More information

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice Quarterly pharmacy formulary change notice Summary of change: The Pharmacy and Therapeutics Committee (P&T) reviewed and approved the formulary changes listed in the table below on March 29, 2016. What

More information

ADDITIONAL 2017 FORMULARY CHANGES CIGNA COMMERCIAL CUSTOMERS

ADDITIONAL 2017 FORMULARY CHANGES CIGNA COMMERCIAL CUSTOMERS ADDITIONAL 2017 FORMULARY CHANGES CIGNA COMMERCIAL CUSTOMERS Effective 7/1/2017, Cigna will be making additional formulary changes that may impact customers at your pharmacy. We have included a list of

More information

Pharmacy Clinical Prior Authorization Assistance Chart Effective February 2018

Pharmacy Clinical Prior Authorization Assistance Chart Effective February 2018 About Pharmacy Clinical Prior Authorizations Clinical prior authorizations (PA) are based on evidence-based clinical criteria and nationally recognized peer-reviewed information. The PA may apply to an

More information

Generic Label Name Drug Strength Dosage Form Example Product (s) MME/Unit ACETAMINOPHEN WITH CODEINE

Generic Label Name Drug Strength Dosage Form Example Product (s) MME/Unit ACETAMINOPHEN WITH CODEINE STATE OF TENNESSEE DEPARTMENT OF FINANCE AND ADMINISTRATION DIVISION OF HEALTH CARE FINANCE AND ADMINISTRATION BUREAU OF TENNCARE 3 Great Circle Road NASHVILLE, TENNESSEE 37243 This notice is to advise

More information

Provider Administered Drug Program (PADP) and Physician Administered Drug VPSS List

Provider Administered Drug Program (PADP) and Physician Administered Drug VPSS List Provider Administered Drug Program (PADP) and Physician Administered Drug VPSS List Code Drug Name Effective and/or Term Date J0129 Injection, abatacept (Orencia ), 10 mg J0178 Injection, aflibercept (Eylea

More information

MedStar Medicare Choice Pharmacy Services

MedStar Medicare Choice Pharmacy Services Pharmacy Services 1 MedStar Medicare Choice Pharmacy Services Table of Contents At a Glance..page 2 Pharmacy Policies..page 4 Medicare Choice Pharmacy Programs..page 6 Where to Obtain Prescriptions..page

More information

Your Drug Coverage Will Change as of Jan. 1, 2017

Your Drug Coverage Will Change as of Jan. 1, 2017 Your Drug Coverage Will Change as of Jan. 1, 2017 October, 2016 Dear Member: Thank you for choosing us for your health and drug coverage. We at Blue Cross and Blue Shield of Louisiana and HMO Louisiana,

More information

ADDITIONAL 2017 FORMULARY CHANGES CIGNA COMMERCIAL CUSTOMERS

ADDITIONAL 2017 FORMULARY CHANGES CIGNA COMMERCIAL CUSTOMERS ADDITIONAL 2017 FORMULARY CHANGES CIGNA COMMERCIAL CUSTOMERS Cigna will be making additional formulary changes that may impact customers at your pharmacy. We have included a list of drugs by drug class

More information

High-Cost Drug Exclusions

High-Cost Drug Exclusions PHARMACY SERVICES High-Cost Exclusions The high cost medications listed below are excluded from coverage because lower cost similar alternatives are available. To help you get the best health benefit at

More information

Texas Prior Authorization Program Clinical Edit Criteria

Texas Prior Authorization Program Clinical Edit Criteria Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Clinical Edit Information Included in this Document Drugs requiring prior authorization: the list of drugs requiring prior authorization

More information

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice Provider Bulletin June 24, 2016 Summary of change The Pharmacy and Therapeutics Committee reviewed and approved the formulary changes listed in the table below on March 29, 2016. What this means to you

More information

P&T/Formulary Committee Actions (1Q18)

P&T/Formulary Committee Actions (1Q18) P&T/Formulary Committee s (1Q18) 1Q2018 Marketplace Standard (HIEx) Additions and/or Revisions effective: April 1, 2018 Deletions effective: April 1, 2018 for NEW member prescriptions; July 1, 2018 for

More information

Your Group s Drug Coverage Will Change as of Jan. 1, 2017 Notice of modification of drug coverage of a particular product

Your Group s Drug Coverage Will Change as of Jan. 1, 2017 Notice of modification of drug coverage of a particular product Your Group s Drug Coverage Will Change as of Jan. 1, 2017 Notice of modification of drug coverage of a particular product October, 2016 Dear Group Leader: Thank you for choosing us for your health and

More information

Oregon Health Plan prescription benefit updates

Oregon Health Plan prescription benefit updates Oregon Health Plan prescription benefit updates EOCCO s prescription program is a pharmacy benefit that offers members a choice of safe and effective medication treatments. The program also helps you save

More information

PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select Formulary October 1, 2018 Updates. Formulary. Alternatives

PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select Formulary October 1, 2018 Updates. Formulary. Alternatives PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select October 1, 2018 Updates Drug Name efavirenz 600mg (Brand = Sustiva ) trientine (Brand = Syprine ) hydrocortisone lot 0.1% (Brand = Locoid ) sumatriptan-naproxen

More information

Drug Formulary Update, October 2016 Commercial and State Programs

Drug Formulary Update, October 2016 Commercial and State Programs Drug Formulary Update, October 2016 Commercial and State Programs Updates to the HealthPartners Commercial and State Program Drug Formularies are listed below. Updates apply to all Commercial groups (PreferredRx,

More information

LIMITED DISTRIBUTION MEDICATIONS

LIMITED DISTRIBUTION MEDICATIONS ACTEMRA IV (USSC can dispense 162 mg PFS) ACTHAR HP ACTIMMUNE ADAGEN ADCETRIS CVS Specialty 1-800-237-2767 1-800-237-2767 ADEMPAS ADVATE ALDURAZYME ALECENSA ALIQOPA ALUNBRIG AMPYRA APOKYN ARALAST NP ARCALYST

More information

Injectable Drugs Requiring Pre-Service Approval

Injectable Drugs Requiring Pre-Service Approval Abatacept Orencia J0129, 10 mg 1500 FL LCD- L29051 1) For patients with rheumatoid arthritis with failure, intolerance or contraindications to methotrexate. Limit dosing to 40 mg Q 2 weeks. 2) For patients

More information

Formulary Changes. One mission: you TABLE A. FORMULARY CHANGES 7/1/2018: Commercial 3-Tier Formulary. Commercial 4-Tier Formulary

Formulary Changes. One mission: you TABLE A. FORMULARY CHANGES 7/1/2018: Commercial 3-Tier Formulary. Commercial 4-Tier Formulary One mission: you Changes July 1, 2018 Blue Cross of Idaho reviews its formularies (covered drug lists) periodically to allow members access to new drugs and to provide safe, cost effective options for

More information

March 2017 Pharmacy & Therapeutics Committee Decisions

March 2017 Pharmacy & Therapeutics Committee Decisions UCare s Pharmacy and Therapeutics Committee (P&T) is a group of physicians and pharmacists that meet throughout the year to make changes to the UCare formulary (approved drug list). These changes are reviewed

More information

Future Formulary Changes

Future Formulary Changes Future Formulary Changes Applies to: Employer group plan 2019 open formularies with specialty tiers KEY: PA=prior authorization; ST=step therapy; QL=quantity limit Obeticholic acid Ocaliva Limited to Kaiser

More information

High-Cost Drug Exclusions

High-Cost Drug Exclusions Pharmacy Services High-Cost Exclusions The high cost medications listed below are excluded from coverage because lower cost similar alternatives are available. To help you get the best health benefit at

More information

Washington October Newsletter

Washington October Newsletter Washington October Newsletter October 19, 2017 CMS Education on Medicare Skilled Nursing and Therapy Services Coverage The Centers for Medicare and Medicaid (CMS) want to remind you that the Jimmo v. Sebelius

More information

Prior Authorization Drug List

Prior Authorization Drug List Prior Authorization Drug List This is a list of drugs that require Prior Authorization before coverage is provided. If you are prescribed a medication that requires Prior Authorization, your physician

More information

FDA strengthens warning that non-aspirin nonsteroidal antiinflammatory drugs (NSAIDs) can cause heart attacks or strokes

FDA strengthens warning that non-aspirin nonsteroidal antiinflammatory drugs (NSAIDs) can cause heart attacks or strokes FDA strengthens warning that non-aspirin nonsteroidal antiinflammatory drugs (NSAIDs) can cause heart attacks or strokes Safety Announcement [7-9-2015] The U.S. Food and Drug Administration (FDA) is strengthening

More information

STAT Bulletin. Drug Therapy Guideline Updates. To: All Primary Care Physicians and Specialists Contracts Affected: All Lines of Business

STAT Bulletin. Drug Therapy Guideline Updates. To: All Primary Care Physicians and Specialists Contracts Affected: All Lines of Business STAT Bulletin November 28, 2011 Volume 9: Issue 27 To: All Primary Care Physicians and Specialists Contracts Affected: All Lines of Business Drug Therapy Guideline Updates Why you re receiving this Stat

More information

Step Therapy Criteria

Step Therapy Criteria Step Therapy Group ADCIRCA 1772-D ADCIRCA Coverage will be provided if the member has filled a prescription for sildenafil (at least a 30 day supply within the past 365 Step Therapy Group ANTIPSYCHOTICS

More information

INJECTABLE MEDICINES. Resources, Links or Additional Information. J Code Brand Names Generic names Prior Authorization or Restrictions

INJECTABLE MEDICINES. Resources, Links or Additional Information. J Code Brand Names Generic names Prior Authorization or Restrictions J9190 5-FU fluorouracil None. J0401 ABILIFY MAINTENA aripiprazole i.v. J9264 ABRAXANE paclitaxel protein bound J3262 ACTEMRA IV tocilizumab Yes, through Navitus. Restricted to (in at least consultation

More information

Aetna Better Health. Specialty Drug Program

Aetna Better Health. Specialty Drug Program Aetna Better Health is managed through CVS Health Specialty Pharmacy. The Specialty pharmacies fill prescriptions and ship drugs for complex medical conditions, including multiple sclerosis, rheumatoid

More information

PA Category Name Code(s) Additional Notes ABA 0364T 0365T 0366T 0367T 0373T 0374T H G0396. Applied Behavioral Analysis stage 3*

PA Category Name Code(s) Additional Notes ABA 0364T 0365T 0366T 0367T 0373T 0374T H G0396. Applied Behavioral Analysis stage 3* ABA BEHAVIORAL HEALTH CHEMICAL DEPENDENCY Applied Behavioral Analysis stage 3* Neuropsychological Testing Chemical Dependency/Substance Abuse* (MA Only) 0364T 0365T 0366T 0367T 0373T 0374T H2020 96116

More information

ELEVATE. Formulary Updates to Elevate Plans (Bronze HDHP/Standard, Silver Select/Standard & Gold Select/Standard)

ELEVATE. Formulary Updates to Elevate Plans (Bronze HDHP/Standard, Silver Select/Standard & Gold Select/Standard) ELEVATE Formulary Updates to Elevate Plans (Bronze HDHP/Standard, Silver Select/Standard & Gold Select/Standard) P&T/Formulary Committee Actions 4Q 2017 (Effective January 1, 2018) Marketplace Standard

More information

APREPITANT ARMODAFINIL BELSOMRA BUPAP BUPRENORPHINE HCL BUTALBITAL-ACETAMINOPHEN BUTALBITAL-APAP-CAFF-COD BUTALBITAL-APAP-CAFFEINE

APREPITANT ARMODAFINIL BELSOMRA BUPAP BUPRENORPHINE HCL BUTALBITAL-ACETAMINOPHEN BUTALBITAL-APAP-CAFF-COD BUTALBITAL-APAP-CAFFEINE APREPITANT Aprepitant Oral Capsule 125, 40, 80 Aprepitant Oral Capsule 80 & 125 Quantity Limit: 8 EA Per 30 Days Quantity Limit: 12 EA Per 30 Days ARMODAFINIL Armodafinil Oral Tablet 150, 200, 250, 50

More information

Future Formulary Changes

Future Formulary Changes Future Formulary Changes Upd 11/21/2018 Applies to: Employer group plan 2018 2019 open formularies KEY: PA=prior authorization; ST=step therapy; QL=quantity limit Generic name Brand name Change Effective

More information

Descriptor Brand Name. Alprostadil, Caverject, Edex, Prostin VR Pediatric. Calcimar, Miacalcin

Descriptor Brand Name. Alprostadil, Caverject, Edex, Prostin VR Pediatric. Calcimar, Miacalcin Self-Administered Drug Exclusion List R2 This article from Medicare A News, Issue 2106 dated January 23, 2013 and Medicare B News, Issue 283 dated January 23, 2013 is being revised to add Acthar ACTH gel

More information

2018 BCN Advantage Prior Authorization Criteria Last updated: April, 2018

2018 BCN Advantage Prior Authorization Criteria Last updated: April, 2018 Abstral Actemra Adcirca Adempas Aliqopa Afinitor Afinitor- Disperz Alecensa Alunbrig Amitiza Amitriptyline Ampyra Anadrol-50 Androgel Androderm Aralast NP Aranesp Arcalyst Armodafinil Aubagio Avonex Bavencio

More information

Drug Class Preferred Agents Non-Preferred Agents

Drug Class Preferred Agents Non-Preferred Agents Commissioner for the Department for Medicaid Services Selections for Preferred Products This is a summary of the final Preferred Drug List (PDL) selections made by the Commissioner of the Department for

More information

Prescription benefit updates Individual/small group

Prescription benefit updates Individual/small group Prescription benefit updates Individual/small group Moda Health s prescription program is a pharmacy benefit that offers members a choice of safe and effective medication treatments. The program also helps

More information

MedPerform Medium Preferred Drug List (PDL)

MedPerform Medium Preferred Drug List (PDL) What is the MedImpact Preferred Drug List (PDL)? The PDL is a list of commonly prescribed medications within select classes of drugs covered by your prescription drug plan. The PDL was created to promote

More information

used for dealing with anxiety. Both of the drugs are also given to patients for dealing with pain activated by damaged or hypersensitive nerves that i

used for dealing with anxiety. Both of the drugs are also given to patients for dealing with pain activated by damaged or hypersensitive nerves that i Aspirin (also classified under NSAIDs or acetylsalicylic acid). Morphine and morphine sustained release (MS-Contin, Avinza, Kadian) Oxymorphone (Opana, Opana ER) Hydrocodone with acetaminophen (Lortab

More information

Your prescription benefit updates Formulary Updates - Effective January 1, 2019

Your prescription benefit updates Formulary Updates - Effective January 1, 2019 Your prescription benefit updates Formulary Updates - Effective January 1, 2019 Medications are grouped by the conditions they treat. Each medication is placed in a tier that shows the amount you will

More information

Opioid Management Program October 2018

Opioid Management Program October 2018 Opioid Management Program October 2018 What Is the Opioid Management Program? This program is based on guidelines developed by the U.S. Centers for Disease Control and Prevention (CDC). It consists of

More information

CENTENE PHARMACY & THERAPEUTICS COMMITTEE SECOND QUARTER 2017 AMBETTER GUIDELINE SUMMARY. Revision Summary or Description

CENTENE PHARMACY & THERAPEUTICS COMMITTEE SECOND QUARTER 2017 AMBETTER GUIDELINE SUMMARY. Revision Summary or Description CENTENE PHARMACY & THERAPEUTICS COMMITTEE SECOND QUARTER 2017 AMBETTER GUIDELINE SUMMARY Coverage Guideline Policy & Procedure HIM.PA.32 Long acting stimulants (Adderall XR, Dexedrine, Metadate CD, Ritalin

More information

STAT Bulletin. Drug Therapy Guideline Updates. To: All Primary Care Physicians and Specialists Contracts Affected: All Lines of Business

STAT Bulletin. Drug Therapy Guideline Updates. To: All Primary Care Physicians and Specialists Contracts Affected: All Lines of Business STAT Bulletin November 28, 2011 Volume 17: Issue 34 To: All Primary Care Physicians and Specialists Contracts Affected: All Lines of Business Drug Therapy Guideline Updates Why you re receiving this Stat

More information

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Medical Policy An independent licensee of the Blue Cross Blue Shield Association Opioid Immediate Release Page 1 of 13 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Opioid Immediate Release Prime Therapeutics will review Prior Authorization

More information

2018 BCN Advantage Prior Authorization Criteria Last updated: November, 2017

2018 BCN Advantage Prior Authorization Criteria Last updated: November, 2017 Abstral Actemra Adcirca Adempas Afinitor Afinitor- Disperz Alecensa Alunbrig Amitiza Amitriptyline Ampyra Anadrol-50 Androgel Androderm Aralast NP Aranesp Arcalyst Armodafinil Aubagio Avonex Bavencio Beleodaq

More information

University System of Georgia Prior Authorization, Step Therapy and Quantity Limit List (Updated 1/1/2016)

University System of Georgia Prior Authorization, Step Therapy and Quantity Limit List (Updated 1/1/2016) University System of Georgia, Step Therapy and Quantity Limit List (Updated 1/1/2016) (PA) Your doctor will need to obtain a prior authorization for the drugs listed below, before your prescription drug

More information

Pharmacy Updates Summary

Pharmacy Updates Summary All of the following changes were reviewed and approved by the SFHP Pharmacy & Therapeutics (P&T) Committee on 7/16/2014 Effective date: 8/15/2014 Therapeutic Classes reviewed: Hepatitis C Ophthalmic Prostaglandins

More information

ALOGLIPTIN STEP. Step Therapy Requirements Effective June 1, 2018

ALOGLIPTIN STEP. Step Therapy Requirements Effective June 1, 2018 Step Therapy Requirements Effective June 1, 2018 ALOGLIPTIN STEP alogliptin 12.5 mg tablet alogliptin 12.5 mg-metformin 1,000 mg tablet alogliptin 12.5 mg-metformin 500 mg tablet alogliptin 12.5 mg-pioglitazone

More information

2016 PRESCRIPTION DRUG LIST UPDATES

2016 PRESCRIPTION DRUG LIST UPDATES 2016 PRESCRIPTION DRUG LIST UPDATES Evergreen Health 1 st Quarter Below are key updates to the four-tier EHB Prescription Formulary, effective January 1, 2016. Please consult the full formulary for more

More information

ACAMPROSATE (CAMPRAL)

ACAMPROSATE (CAMPRAL) ACAMPROSATE (CAMPRAL) ACAMPROSATE CALCIUM Creatinine clearance less than 30 PAGE 1 LAST UPDATED 06/2016 ADALIMUMAB (HUMIRA) HUMIRA, HUMIRA PEDIATRIC CROHN'S, HUMIRA PEN, HUMIRA PEN CROHN'S-UC-HS, HUMIRA

More information

Rationale for Decision Excluded Generic OTC equivalent available (Flonase Allergy Relief) Medicare status (if differs)

Rationale for Decision Excluded Generic OTC equivalent available (Flonase Allergy Relief) Medicare status (if differs) BLUE SHIELD OF CALIFORNIA FIRST QUARTER 2015 FORMULARY AND MEDICATION POLICY UPDATES EFFECTIVE MARCH 19, 2015 The Blue Shield of California (BSC) Pharmacy and Therapeutics (P&T) Committee, consisting of

More information

Opioid Management Program May 2018

Opioid Management Program May 2018 Opioid Management Program May 2018 What Is the Opioid Management Program? This program is based on guidelines developed by the U.S. Centers for Disease Control and Prevention (CDC). It consists of daily

More information

Prescription benefit updates Large group

Prescription benefit updates Large group Prescription benefit updates Large group Moda Health s prescription program is a pharmacy benefit that offers members a choice of safe effective medication treatments. The program also helps you save money

More information

Specialty Pharmacy Pipeline

Specialty Pharmacy Pipeline Specialty Pharmacy Pipeline Drugs to Watch Anticipated Launches Q1 Q2 2017 Atopic Dermatitis Dupixent (dupilumab) Subcutaneous injection Regeneron Pharmaceuticals/Sanofi moderate-to-severe atopic dermatitis

More information

Pharmacy and Medical Guideline Updates

Pharmacy and Medical Guideline Updates STAT Bulletin PO Box 15013 Albany, New York 12212 August 2, 2010 Volume 8: Issue 19 To: All PCPs and Specialists Contracts Affected: All Lines of Business Pharmacy and ical Guideline Updates As a result

More information

Drug List exclusions for Blue Cross commercial plans

Drug List exclusions for Blue Cross commercial plans Drug List exclusions for Blue Cross commercial plans The drugs shown below aren t covered on the commercial Blue Cross Blue Shield of Michigan drug lists. In most cases, if you fill a prescription for

More information

Specialty Drugs. The following is a list of medications that are considered to be specialty drugs. Specialty drugs

Specialty Drugs. The following is a list of medications that are considered to be specialty drugs. Specialty drugs Specialty Drugs The following is a list of medications that are considered to be specialty drugs. Specialty drugs include self-administered injectables, medications that are high cost, and/or medications

More information

ALOGLIPTIN STEP. Details. Step Therapy Requirements Effective November 1, 2017

ALOGLIPTIN STEP. Details. Step Therapy Requirements Effective November 1, 2017 ALOGLIPTIN STEP alogliptin 12.5 mg tablet alogliptin 12.5 mg-metformin 1,000 mg tablet alogliptin 12.5 mg-metformin 500 mg tablet alogliptin 12.5 mg-pioglitazone 15 mg tablet alogliptin 12.5 mg-pioglitazone

More information

Prescription Drug Benefit Rider V

Prescription Drug Benefit Rider V Prescription Drug Benefit Rider V Your Certificate of Coverage is amended as described in this document. This Rider becomes a part of your Certificate of Coverage and is subject to all provisions of your

More information

ALOGLIPTIN STEP. Step Therapy Requirements Effective April 1, 2018

ALOGLIPTIN STEP. Step Therapy Requirements Effective April 1, 2018 Step Therapy Requirements Effective April 1, 2018 ALOGLIPTIN STEP alogliptin 12.5 mg tablet alogliptin 12.5 mg-metformin 1,000 mg tablet alogliptin 12.5 mg-metformin 500 mg tablet alogliptin 12.5 mg-pioglitazone

More information

Drug Formulary Update, April 2017 Commercial and State Programs

Drug Formulary Update, April 2017 Commercial and State Programs Drug Formulary Update, April 2017 Commercial and State Programs Updates to the HealthPartners Commercial and State Program Drug Formularies are listed below. Updates apply to all Commercial groups (PreferredRx,

More information

FirstCarolinaCare Preferred Drug List (PDL)

FirstCarolinaCare Preferred Drug List (PDL) FirstCarolinaCare Preferred Drug List (PDL) 2-tier Drug Plan Members What is the MedImpact Preferred Drug List (PDL)? The PDL is a list of commonly prescribed medications within select classes of drugs

More information

Diabetes Fortamet (metformin ER), Glumetza (metformin ER) generic of Glucophage XR (metformin ER) preferred

Diabetes Fortamet (metformin ER), Glumetza (metformin ER) generic of Glucophage XR (metformin ER) preferred Pennsylvania Employees Benefit Trust Fund (PEBTF) and n-medicare Eligible Retired Employees Health Program (REHP), Step Therapy and Quantity Limit List Your doctor needs to get prior authorization for

More information

FirstCarolinaCare Preferred Drug List (PDL)

FirstCarolinaCare Preferred Drug List (PDL) 3-tier Drug Plan Members What is the MedImpact Preferred Drug List (PDL)? The PDL is a list of commonly prescribed medications within select classes of drugs covered by your prescription drug plan. The

More information

STEP THERAPY CRITERIA

STEP THERAPY CRITERIA STEP THERAPY This is a complete list of drugs that have written coverage determination policies. Drugs on this list do not indicate that this particular drug will be covered under your medical or prescription

More information

Tribute 2018 Formulary 2018 Quantity Limit Criteria

Tribute 2018 Formulary 2018 Quantity Limit Criteria APREPITANT Aprepitant ORAL CAPSULE 125, 40, 80 Aprepitant Oral CAPSULE 80 & 125 Quantity Limit: 8 EA Per 30 Days Quantity Limit: 12 EA Per 30 Days ARMODAFINIL Armodafinil ORAL TABLET 150, 200, 250, 50

More information